Amirhossein Sahebkar

Amirhossein Sahebkar
امیرحسین صاحبکار
EducationMashhad University of Medical Sciences (PharmD, PhD)
Scientific career
FieldsMedical biotechnology, cardiovascular disease
WorkplacesMashhad University of Medical Sciences

Amirhossein Sahebkar is an Iranian biotechnologist specializing in cardiovascular diseases. He is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.

Life

Sahebkar completed a professional doctorate in pharmacy (Pharm.D.) in 2008 from Mashhad University of Medical Sciences.[1] Sahebkar earned a Ph.D. in pharmaceutical biotechnology from the Mashhad University of Medical Sciences. He has completed fellowship careers in cardiometabolic diseases at the University of Western Australia, International Atherosclerosis Society, and Mashhad University of Medical Sciences. He is a fellow of the European Society of Cardiology and American College of Cardiology, and serves as the National Lead Investigator for the European Atherosclerosis Society. He is also an adjunct professor of universities outside of Iran. His primary research focus lies in basic and clinical studies aimed at developing novel therapeutic strategies for cardiometabolic diseases.[2] He has been selected by Clarivate Analytics among global top 1% highly cited researches across different scientific fields.

Sahebkar is a Professor in the department of medical biotechnology at the Mashhad University of Medical Sciences.[3] His research focuses on cardiovascular disease, atherosclerosis, and blood lipids.[3] He is a member of the Iran's National Elites Foundation.[1] In 2016, he was presented the Professor Dr. Fereydoun Azizi award by the Iranian Academy of Medical Sciences.[3][2] He has also been awarded several national and international awards, and holds Adjunct Professor positions at universities outside of Iran.

As of April 2026, Sahebkar has co-authored more than 2000 PubMed-indexed articles[4], of which 11 have been retracted. Five of those retractions[5][6][7][8][9] are due to irregularities at the publisher Hindawi, where an investigation discovered more than 7000 articles with "systematic manipulation of the publication and peer-review process" and / or potentially connected to paper mills.[10] Six further retractions[11][12][13][14][15][16] are due to data and / or image irregularities.

References

  1. 1 2 Sahebkar, Amirhossein. "Resume". USERN. Retrieved 2024-02-17.
  2. 1 2 "دانشمند برگزیده دهه اخیر کشور در علوم‌پزشکی کیست؟". www.khabaronline.ir (in Persian). 2018-02-02. Retrieved 2024-02-17.
  3. 1 2 3 "انتخاب دکتر صاحبکار بعنوان دانشمند برگزیده دهه اخیر در حوزه علوم پزشکی". ایسنا (in Persian). 2018-02-02. Retrieved 2024-02-17.
  4. ↑ ""Sahebkar A"[Author] - Search Results - PubMed". PubMed. Retrieved 2026-04-05.
  5. ↑ Aalami, Amir Hossein; Abdeahad, Hossein; Mesgari, Mohammad; Sathyapalan, Thozhukat; Sahebkar, Amirhossein (2021-04-27). Xu, Zhenbo (ed.). "Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis". BioMed Research International. 2021: 1–10. doi:10.1155/2021/5557309. ISSN 2314-6141. PMC 8099530. PMID 33997007. (Retracted, see doi:10.1155/2024/9869348, PMID 38230192,  Retraction Watch)
  6. ↑ Korani, Shahla; Rashidi, Khodabakhsh; Hamelian, Mona; Jalalvand, Ali R.; Tajehmiri, Ahmad; Korani, Mitra; Sathyapalan, Thozhukat; Sahebkar, Amirhossein (2021-10-22). Tan, Songwen (ed.). "Evaluation of Antimicrobial and Wound Healing Effects of Gold Nanoparticles Containing Abelmoschus esculentus (L.) Aqueous Extract". Bioinorganic Chemistry and Applications. 2021: 1–13. doi:10.1155/2021/7019130. ISSN 1687-479X. PMC 8556124. PMID 34721559. (Retracted, see doi:10.1155/2023/9787048, PMID 38093938,  Retraction Watch)
  7. ↑ Ganjali, Shiva; Mansouri, Atena; Abbasifard, Mitra; Moallem, Seyed Adel; Tayarani-Najaran, Zahra; Sahebkar, Amirhossein (2022-06-28). Cao, Jianlei (ed.). "Association between Oxidative Burden and Restenosis: A Case-Control Study". Oxidative Medicine and Cellular Longevity. 2022: 1–10. doi:10.1155/2022/3577761. ISSN 1942-0994. PMC 9256427. PMID 35799893. (Retracted, see doi:10.1155/2024/9830842, PMID 38234566,  Retraction Watch)
  8. ↑ Jamialahmadi, Tannaz; Baratzadeh, Fatemeh; Reiner, Željko; Mannarino, Massimo R.; Cardenia, Vladimiro; Simental-Mendía, Luis E.; Pirro, Matteo; Watts, Gerald F.; Sahebkar, Amirhossein (2022-08-01). Cao, Jianlei (ed.). "The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis". Oxidative Medicine and Cellular Longevity. 2022: 1–15. doi:10.1155/2022/7850659. ISSN 1942-0994. PMC 9359854. PMID 35958018. (Retracted, see doi:10.1155/2024/9849024, PMID 38234524,  Retraction Watch)
  9. ↑ Stamerra, Cosimo Andrea; Di Giosia, Paolo; Giorgini, Paolo; Ferri, Claudio; Sukhorukov, Vasily N.; Sahebkar, Amirhossein (2022-08-02). Cao, Jianlei (ed.). "Mitochondrial Dysfunction and Cardiovascular Disease: Pathophysiology and Emerging Therapies". Oxidative Medicine and Cellular Longevity. 2022: 1–16. doi:10.1155/2022/9530007. ISSN 1942-0994. PMC 9363184. PMID 35958017. (Retracted, see doi:10.1155/2024/9785792, PMID 38234576,  Retraction Watch)
  10. ↑ Kincaid, Ellie (2023-12-06). "Wiley to stop using "Hindawi" name amid $18 million revenue decline". Retraction Watch. Retrieved 2024-08-24.
  11. ↑ Mirzaei, Hamed; Salehi, Hossein; Oskuee, Reza Kazemi; Mohammadpour, Ali; Mirzaei, Hamid Reza; Sharifi, Mohammad Reza; Salarinia, Reza; Darani, Hossein Yousofi; Mokhtari, Mojgan; Masoudifar, Aria; Sahebkar, Amirhossein; Salehi, Rasoul; Jaafari, Mahmoud Reza (2018-04-10). "RETRACTED: The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model". Cancer Letters. 419: 30–39. doi:10.1016/j.canlet.2018.01.029. ISSN 0304-3835. PMID 29331419. (Retracted, see doi:10.1016/j.canlet.2024.216670, PMID 38307748)
  12. ↑ Momtazi-Borojeni, Amir Abbas; Jaafari, Mahmoud Reza; Badiee, Ali; Banach, Maciej; Sahebkar, Amirhossein (2019-12-10). "RETRACTED ARTICLE: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis". BMC Medicine. 17 (1): 223. doi:10.1186/s12916-019-1457-8. ISSN 1741-7015. PMC 6902459. PMID 31818299. (Retracted, see doi:10.1186/s12916-023-02884-w, PMID 37143044)
  13. ↑ Marjaneh, Reyhaneh Moradi; Rahmani, Farzad; Hassanian, Seyed Mahdi; Rezaei, Nastaran; Hashemzehi, Milad; Bahrami, Afsane; Ariakia, Fatemeh; Fiuji, Hamid; Sahebkar, Amirhosein; Avan, Amir; Khazaei, Majid. "RETRACTED: Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer". Journal of Cellular Physiology. 233 (10): 6785–6798. doi:10.1002/jcp.26538. ISSN 0021-9541.
  14. ↑ Hashemzehi, Milad; Behnam‐Rassouli, Reihane; Hassanian, Seyed Mahdi; Moradi‐Binabaj, Maryam; Moradi‐Marjaneh, Reyhaneh; Rahmani, Farzad; Fiuji, Hamid; Jamili, Mahdi; Mirahmadi, Mahdi; Boromand, Nadia; Piran, Mehran; Jafari, Mohieddin; Sahebkar, Amirhossein; Avan, Amir; Khazaei, Majid. "RETRACTED: Phytosomal‐curcumin antagonizes cell growth and migration, induced by thrombin through AMP‐Kinase in breast cancer". Journal of Cellular Biochemistry. 119 (7): 5996–6007. doi:10.1002/jcb.26796. ISSN 0730-2312.
  15. ↑ Moradzadeh, Maliheh; Tabarraei, Alijan; Sadeghnia, Hamid Reza; Ghorbani, Ahmad; Mohamadkhani, Ashraf; Erfanian, Saiedeh; Sahebkar, Amirhossein. "RETRACTED: Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes". Journal of Cellular Biochemistry. 119 (2): 2288–2297. doi:10.1002/jcb.26391. ISSN 0730-2312.
  16. ↑ Moradzadeh, Maliheh; Roustazadeh, Abazar; Tabarraei, Alijan; Erfanian, Saiedeh; Sahebkar, Amirhossein. "RETRACTED: Epigallocatechin‐3‐gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML‐RARα and HDAC1". Phytotherapy Research. 32 (3): 471–479. doi:10.1002/ptr.5990. ISSN 0951-418X.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.